CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV.

Chia-Chen LinShih-Huan SuWen-Juei JengChien-Hao HuangWei TengWei-Ting ChenYi-Cheng ChenYung-Chang LinI-Shyan Sheen

Published in: BMC gastroenterology (2017)

IL28B genotype is the predictor for NR in GT-1 CHC patients treated with PegIFN/RBV, while baseline serum level of CCL4 is the only predictor for NR in GT-1 CHC patients with favorable IL28B genotype.

Keyphrases

liver fibrosis